Abstract
Homotypic and heterotypic interactions between cells are of crucial importance in multicellular organisms for the maintenance of physiological functions. Accordingly, changes in cell-to-cell communication contribute significantly to tumor development. Cancer cells engage the different components of the tumor microenvironment (TME) to support malignant proliferation, escape immune control, and favor metastatic spreading. The interaction between cancerous and non-cancerous cell types within tumors occurs in many ways, including physical contact and paracrine signaling. Furthermore, local and long-range transfer of biologically active molecules (e.g., DNA, RNA, and proteins) can be mediated by small extracellular vesicles (EVs) and this has been shown to influence many aspects of tumor progression. As it stands, there is a critical need for suitable experimental systems that enable modeling the cell-to-cell communications occurring in cancer. Given their intrinsic complexity, animal models represent the ideal system to study cell-to-cell interaction between different cell types; however, they might make difficult to assess individual contribution to a given phenotype. On the other hand, simplest experimental models (i.e., in vitro culture systems) might be of great use when weighing individual contributions to a given phenomenon, yet it is imperative that they share a considerable number of features with human cancer. Of the many culture systems available to the scientific community, patient-derived organoids already proved to faithfully recapitulate many of the traits of patients’ disease, including genetic heterogeneity and response to therapy. The organoid technology offers several advantages over conventional monolayer cell cultures, including the preservation of the topology of cell-to-cell and cell-to-matrix interactions as observed in vivo. Several studies have shown that organoid cultures can be successfully used to study interaction between cancer cells and cellular components of the TME. Here, we discuss the potential of using organoids to model the interplay between cancer and non-cancer cells in order to unveil biological mechanisms involved in cancers initiation and progression, which might ultimately lead to the identification of novel intervention strategy for those diseases.
Introduction
Homotypic and heterotypic interactions between cells are of crucial importance in multicellular organisms for the maintenance of physiological functions, including embryonic development, neurotransmission, wound healing, and inflammation. An individual cell can interact with a heterogeneous group of cells in multiple ways, that is through physical contact, ligand–receptor interactions, cellular junctions or through secreted mediators. Non-cellular components of the extracellular microenvironment add another layer of complexity to this phenomenon. Indeed, the extracellular matrix (ECM) has many functions besides providing mechanical support for organs, tissues, and individual cells. ECM, which is rich in collagens, proteoglycans, hyaluronic acid, laminins and fibronectin, is constantly remodeled in physiological processes, especially during development and wound repair, as well as in many diseases. Its degradation and reassembly regulate cell proliferation, differentiation, survival, and migration (). ECM proteins can bind either to adhesion receptors (e.g., integrins) to transduce intracellular signals or growth factors to regulate their presentation to cells (). The cell communication process and its regulation acquire major importance in the cancer contest, where cancer cells interact and communicate with a variety of non-cancerous cells, including normal epithelial cells, immune cells, endothelial cells and fibroblasts, which collectively constitute the tumor microenvironment (TME). In addition, recent evidences suggest a major role for a cell-to-cell communication system that involve extracellular vesicles (EVs) transferring biologically active molecules, which can substantially modify the cellular behavior of recipient cells (; ). As it stands, complex interactions that occur in the TME need to be taken into account when modeling cancer. Driven by recent advances in cell culture technology and EVs isolation methods, we review how next generation culture systems, in particular organoids, represent a promising tool to help modeling cell-to-cell communication. Finally, we highlight some of the challenges that researchers are still facing with organoid cultures, including lack of standardization of ECM and media being used to support organoid formation and expansion.
Models to Study Cancer Cells Interactions Within the TME
Animal models represent the gold standard to study interactions between cancer cells and the microenvironment. Transplantation of patient-derived tumor’ tissue or cells in immunocompromised mice (Patient-derived xenografts, PDXs) is widely used in preclinical studies to model drug responses. Even if PDXs are considered a good avatar of primary human tumors, recent evidences suggest that generation of xenografts is associated to selection of genetic clones (; ). Furthermore, PDXs fail to properly recapitulate the interaction with the human immune system due to species-specific differences. Genetically engineered mouse models (GEMMs) spontaneously develop tumors in an immune-proficient microenvironment, yet their fast progression and homogeneous genetic background fail to replicate properly the heterogeneity of human diseases (). Humanized immune reconstituted (HIR) mice offer the possibility of transplanting patients’ tumors in a host that at least partially recapitulate the human immune system, thus providing a more realistic representation of the disease. Nonetheless, the use of HIR mice models is less straightforward, due to species-specific differences and incorrect representation of the patients’ immune system ().
Although animal models provide a more realistic platform to model the disease as a whole, their intrinsic complexity makes difficult assessing individual contributions to a given phenotype. On the other hand, in vitro two-dimensional (2D) and three-dimensional (3D) cell culture systems represent a facile platform to understand causative relationships in cancer through different type of perturbation analyses (i.e., genetic and non-genetic).
Conventional monolayer cell culture systems have been of tremendous importance for the current understanding of many diseases, including cancers; however, they suffer from several limitations making them inappropriate to correctly model patients’ tumors. A comprehensive evaluation of the advantages of 3D culture systems over 2D systems is beyond the scope of this review, and it has been extensively described elsewhere (; ; ; ).
The most commonly used 3D culture models are spheroids and organoids. Spheroids are cell aggregates or spheres cultured primarily in suspension, which are likely enriched for stem-like cell population (). This technology can be applied to both cancer cell lines and patient-derived tumor cells, but it is not applicable to normal cells from many tissues. The use of spheroids ranges from drug screening to modeling immune interactions (). Spheroids partially compensate deficiencies of monolayer cultures; the formation of an aggregate creates a gradient of nutrients, oxygen and metabolites, and models cell-to-cell and cell-to-matrix interactions (). Beyond a few exceptions (i.e., secretory acini spheroids) (), the random aggregations of cells, and the consequent lack of organization in tissue-like structures, makes spheroids poor models of epithelial tissues (). On the other hand, we defined organoids as 3D cultures derived directly from the dissociation of specialized epithelial tissues, from embryonic stem cells (ESCs) or induced pluripotent stem cells (iPSCs), all showing self-renewal and self-organization capabilities (). Furthermore, organoids are capable of preserving many relevant features of in vivo tissue physiology. Studies of tissue morphogenesis and early 3D cultures of mouse mammary primary cells (; ) set the ground for the subsequent development of the organoid technology. The laboratory of Mina Blissell was the first to show that primary epithelial cells from mouse mammary glands could self-organize in glandular structures and express milk proteins when cultured in a basement membrane matrix (BM). The BM used in that seminal work was isolated from mouse Engelbreth-Holm-Swarm (EHS) sarcoma (), currently branded as Matrigel® (; ), and mainly composed by a mixture of collagen type IV, laminin, heparan sulfate proteoglycans, and entactin.
Few years later, the same method was applied to the propagation of human cells derived from both normal and tumoral tissues (). Notwithstanding the important earlier studies, the first organotypic models were reported in 2008 and in 2009 to enable growing cortical neurons () and intestinal epithelium (), respectively. In 2009, the Clevers’ group () described the method for the generation of organoid cultures from individual Lgr5+ stem cells isolated from mouse intestinal tissue. The Lgr5+ cells are embedded in Matrigel® and overlaid with a defined culture medium supplemented with several growth factors and morphogens that substitute for stromal cues. The resulting organoids consisted of a monolayer of epithelial cells surrounding a central lumen as well as of protrusions containing stem cells and differentiated Paneth cells that form the stem cells niche. Hereafter, the procedure was adapted for the generation of organoids from human small intestine (), which showed some differences compared to mouse organoids: human organoids exhibited a more cyst-like morphology with a concomitant increased need for Wnt signaling stimulation. The establishment of organoid cultures have been later reported from several human normal epithelial tissues (; ; , ; ; ). The possibility of growing normal epithelial cells without the need for genetic immortalization (e.g., through exogenous expression of viral genes) probably represents one of the major advantages of the organoid technology. Normal tissue-derived organoids might be used to study the mutual influence between healthy and cancer cells and to discover cancer-specific interactions within the TME. Nonetheless, they offer new opportunities for regenerative medicine applications (). Building on the seminal studies of the Clevers’ group, modifications of the original procedure were used for culturing human organoids derived from hPSCs () as well as from neoplastic tissues. To date, patient-derived organoids have been established from different cancer tissues, including colon (), brain (), gastric (), pancreatic (), prostate (), liver (), breast (), esophageal (), kidney (), and lung () cancers. Another organoid culture system has been reported by the Calvin Kuo’s lab, known as air liquid interface (ALI) system (). In this system, organoids are grown in a stromal matrix constituted by type I collagen that has an apical side, exposed to the air, and a basolateral side in contact with the media (). Although they first applied it to mouse-derived normal intestinal epithelia, the same method was then applied to normal and tumoral tissues derived from both mouse and human (; , ; ; ).
Tumor Organoid Co-Cultures Model the Interactions With TME
Organotypic cultures, like 2D cell lines, usually contain only one cell type representing the neoplastic epithelium, therefore lacking the multi-cellular representation of the TME. This limitation can be partly solved by the ability of patient-derived cancer organoids to be easily co-cultured with a variety of cell types, including patient-derived immune cells or cancer-associated fibroblast (CAFs) (Figure 1A; ; ; ; ; ; ). 3D co-culture system offers a promising tool to model the interactions between tumor cells and the other cells that compose the TME.
FIGURE 1
Co-cultures With CAFs
Cancer-associated fibroblast constitute the major cellular component of the TME in many tumors () and can be recruited at the tumor site or differentiated from resident mesenchymal cells. Their increased expression/secretion of tumor-promoting factors, collagen, and other ECM proteins distinguish them from the normal fibroblast population. CAFs influence tumor growth and metastasis by several mechanisms. Via matrix synthesis and remodeling, they can modulate ECM stiffness and hypoxia facilitating tumor cells mobility and invasion. Through secreted molecules, such as growth factors, cytokines, chemokines and microRNAs (miRNAs), CAFs support tumor growth and induce resistance to therapy (; ). Moreover, a direct cell-to-cell contact between CAFs and cancer cells, mediated by N-cadherin/E-cadherin adhesion complex, has been recently proved to promote tumor invasion (). However, CAFs targeting experiments evidenced a more complex response than expected. For instance, the ablation of contractile isoform of alpha smooth muscle actin (α-SMA) cells in a mouse model of pancreatic ductal adenocarcinoma (PDAC) was found to reduce cancer desmoplasia, yet resulted in more aggressive and highly undifferentiated tumors, suggesting that the presence of this cell type influence the trajectory of tumor development and progression (). Similar results were obtained with the deletion of Sonic Hedgehog I, a ligand that enhances the formation of fibroblast-rich desmoplastic stroma in PDAC (). The contradictory results evidence the need to investigate more in deep the different subgroups of CAFs and their functions.
Pancreatic cancer organoids exemplify a culture system that can be used to model interaction between cancer cells and CAFs. developed a co-culture system that is able to recapitulate some of the features of the desmoplastic reaction as observed in patients. They demonstrated the existence of two CAFs subpopulations, which are differentially located in tumor tissues and display distinct phenotypes. Those populations were defined as myofibroblasts (myCAFs), proximal to the neoplastic cells and characterized by high levels α-SMA, and as pro-inflammatory CAFs (iCAFs), which are distally located from the cancer cells and have low expression of α-SMA and high expression of IL-6. Using two different types of co-culture, they demonstrated the possibility of modeling CAFs subtypes using an in vitro system. The co-culture was established using pancreatic stellate cells, which are resident mesenchymal cells expressing fibroblast-activation protein α (FAP), and pancreatic organoids established either from patients or mouse tumors. When both cancer cells and fibroblasts are embedded together in Matrigel® (Figure 1B), the close contact induced an activation of quiescent PSCs, with the acquisition of myCAFs phenotype. When the two cell types are physically separated (Figure 1C), yet sharing the growth medium, there was emergence of the iCAFs phenotype. The results obtained with the two co-culture methods sustained the concept of CAFs intratumoral heterogeneity, further supported by recent single cell RNA sequencing data on bulk PDAC tissue, that identified a third subtype, named antigen presenting CAFs (apCAFs), characterized by the expression of MHC class II related genes. Interestingly, all these subtypes are dynamic and reversible ().
An additional type of co-culture has been employed to investigate the role of CAFs in supporting the growth of pancreatic cancer organoids (). In this study, pancreatic organoids and CAFs were dissociated into single cells and then aggregated before being transferred in a Matrigel®/collagen mixture (Figure 1D). This physical attachment allowed the CAFs to supply the organoids with the niche factor necessary for their growth. In agreement with these findings, a 3D co-culture model of prostate organoids and stroma enhanced the formation and induced a change in the morphology of organoids from spherical shape in mono-culture to branched acini structure in co-culture, more similar to what is observed in vivo ().
Cancer-associated fibroblast represent an abundant non-neoplastic cell type also in breast cancers, in which they are implicated in tumor progression and resistance to both chemo- and targeted-therapies (). A 3D co-culture approach has been employed to investigate the modifications in gene expression and cell metabolism of breast cancer cells induced by the interaction with CAFs. After pre-coating the plate with a thin layer of Matrigel®, the two cell types were aggregated and cultured on top of the laminin-rich ECM (; Figure 1E). This method uncovered the effects of CAFs in attenuating the accumulation in epithelial cells of Lapatinib, a tyrosine kinase inhibitor used in the treatment of breast cancer ().
Co-cultures With Immune Cells
Immune cells have antithetic functions in the TME. Innate and adaptive immune systems both exert their influence on TME and in turn are affected by TME. Macrophages, one of the most abundant cell types in the tumor stroma, are innate immune system phagocytic cells that can have pro- or anti-tumor activity. M1 macrophages are pro-inflammatory and considered tumor suppressive, but when they interact with the TME they undergo a phenotypic switch toward the M2 phenotype, known to be anti-inflammatory and tumor promoting. The integration of peripheral blood-derived macrophages in a 3D co-culture system of squamous cell carcinoma allowed the modulation of the macrophages phenotype. The classical protocol for polarization of macrophages involve the use of recombinant INF-γ and LPS to induce the M1 phenotype, while IL-4 stimulation promotes the M2 phenotype. Interestingly, the prolonged co-culture with cancer cells was sufficient to cause the spontaneous switch of macrophages phenotype toward M2, even in absence of IL-4 (). Adaptive immune cells, like CD8+ T cells, are subjected to TME influence as well. CD8+ T cells are major actors of anti-cancer immunity; their infiltration in TME has been reported to correlate with better prognosis in several malignancies such as melanoma, ovarian, pancreatic, breast and colorectal cancers (; ; ; ). CD8+ T cells act by recognizing tumor-associated antigens presented to their T cell receptor by major histocompatibility complex (MHC). However, tumors often activate immune evasion mechanisms that include secretion of immunosuppressive cytokines, MHC downregulation or resistance to T cell-mediated cell death (). The programmed death 1 (PD-1) immune checkpoint is a key player in the tumor-mediated immune evasion mechanisms. When PD-1 interacts with one of its ligands, PD-L1 or PD-L2, activates the recruitment of SHP-2, which functions suppressing T-cell receptor signaling, inducing tumor-specific T-cells exhaustion or apoptosis. In tumor, PD-L1 is expressed not only by cancer cells but also by cells of TME or antigen presenting cells. PD-1/PD-L1 complex is one of the targets of cancer immunotherapy based on immune checkpoint inhibitors (ICI), which aims at unleashing anti-tumor responses by activating immune cells. Unfortunately, only subsets of epithelial cancers patients have shown benefit from cancer immunotherapies based on ICI. While genome sequencing data have largely contributed to the identification of biomarkers predictor of response, the molecular mechanisms of sensitivity/resistance are still unclear. Recently, described a patient personalized in vitro model that enable the induction and the analysis of tumor specific T cell responses. Organoids were established from mismatch repair deficient colorectal cancer and from non-small-cell lung cancer patients, while T lymphocytes were isolated from patient’ peripheral blood. The co-culture of tumor organoids and peripheral blood lymphocytes (Figure 1F) allowed the expansion of tumor-reactive T cells, which were able to kill tumor organoids but not the ones derived from healthy tissue. This platform permits the study of tumor and T cells interactions with the potential to uncover the determinants of sensitivity or resistance to immunotherapy in a personalized manner. Another platform has been described by and is based on a 3D microfluidic device, which enabled preservation of both tumor infiltrating lymphoid and myeloid cells along with tumor-spheroids. Using this system, patient-derived organotypic tumor spheroids proved to be a good model to study tumor-immune interactions and responses to PD-1 blockade. In addition, a peculiar co-culture method based on ALI system () permitted the propagation of patient-derived organoids and tumor-infiltrating lymphocytes. In this system, minced tumor tissues are resuspended in type I collagen and plated on a permeable insert precoated with collagen matrix (Figure 1G). The ALI culture system was found to preserve the native stromal populations, including fibroblasts, macrophages and lymphocytes, for up to 2 months. Importantly, tumor-infiltrating lymphocytes maintained the T cell receptor repertoire observed in patients and the patient-derived organoids response to anti-PD-1 Nivolumab in vitro was comparable to what has been observed in clinical trials.
New Horizons of Organoids Application: Modeling EVs Release
Communication between cancerous cells and TME is also achieved through release of extracellular vescicles (EVs), a heterogeneous population of double-layer phospholipid membrane vesicles released by most cell types. The different populations of EVs can be discriminated by vesicle size, biogenesis, and release pathway. Microvesicles are vesicles with a diameter ranging from 200 to 2000 nm that originate directly from the budding of the cellular membrane (). Exosomes are smaller vesicles, with a diameter less than 200 nm, derived from intracellular endosomal compartment, called multivesicular body, and released by the fusion of the multicellular body with the plasma membrane (). Another type of EVs is represented by apoptotic bodies that originate during the late stages of programmed cell death and containing part of cytoplasm (). Several findings support the hypothesis that the bioactive molecules encapsulated in the EVs are capable of modifying the functions of the recipient cells. Tumor-derived EVs, also referred as oncosomes due to the fact that their cargo is composed by oncogenic macromolecules (), have been proven to induce changes in the phenotype of neighboring as well as distant cells, promoting tumor growth and local invasion in different cancer types (; ; ). In addition, atypically large (1–10 μm in diameter) EVs derived from amoeboid tumor cells have been recently identified in the circulation of different mouse models of prostate cancer as well as in the biological fluids of metastatic prostate cancer patients (). This so-called large oncosomes (LOs) are not detected in samples from healthy donors and appear to originate from the shedding of non-apoptotic plasma membrane blebs (, ).
Extracellular vescicles are also released by stromal cells in the TME to exert their influence on cancer cells. ANXA6+ (Annexin 6/LDL receptor-related protein-1/thrombospondin-1 complex) CAFs-secreted EVs enhanced tumor cell aggressiveness in pancreatic cancer (). Fibroblast-derived exosomes induced mobilization, invasion (), resistance to therapy and tumor recurrence in breast cancer (), while CAFs EVs-mediated transfer of proteins and lipids enhanced cancer proliferation rate of human prostate cancer and melanoma cell lines (). The EVs transfer of surface receptors or intracellular material has been also associated with immunosuppressive and tumor-promoting functions. The expression of immunomodulatory molecules on exosomes surface contributes to tumor immunosuppression. Fas ligand on exosomes induces T-cell apoptosis in a prostate cancer cell model (), while expression of PD-L1 suppresses the function of CD8+ T cells thereby enhancing tumor growth in a xenograft mouse model of melanoma (). Moreover, melanoma EVs interact with B lymphocytes in lymph nodes and mediate alteration of antitumor immunity promoting cancer progression (). Additional evidences proved that lung cancer-derived exosomes engineered to overexpressed CD40 ligand, part of a critical signaling for the activation of dendritic cells, induced dendritic cells maturation with a consequent increase in T cells proliferation and antitumor activity ().
Based on the “Seed and Soil” hypothesis proposed by Paget in 1889, several works have been published demonstrating that tissues distant from the site of the primary tumor, undergo processes of adaptation to become permissive for the growth of cancer cells. The Lyden’ s group unveiled the role of exosomes in this process (; ; ). They proved that the transfer of MET oncoprotein by melanoma-derived exosomes is able to educate bone marrow progenitor cells to become pro-metastatic, leading to the discovery of an exosome signature with prognostic and therapeutic potential (). More recently, they described the sequential steps necessary for the formation of the pre-metastatic niche in pancreatic cancer, uncovering MIF as potential prognostic marker for liver metastasis (). Moreover, proteomic analysis of tumor-derived exosomes revealed how the exosomal integrin signature is determinant for the formation of the pre-metastatic niche in specific tissues, explaining why tumors may have distinct metastatic tropisms (). Tumor-derived EVs are also implicated in the remodeling of the ECM. EVs isolated from ovarian cancer cell lines were able to compromise the mesothelium integrity and to promote peritoneal dissemination of tumor cells in mice ().
Given increasing evidences of a critical role of EVs in driving cancer progression, implementation and refinement of in vitro system to model EV-mediated cell communication is urgently needed. Monolayer cell cultures have been historically used to investigate the content and role of EVs in cancer, and most of data reported above have been generated using 2D cell culture systems. have recently compared biochemical features, small RNA transcriptome, and proteome of EVs released by two gastric cell lines when cultured in 2D and 3D conditions to uncover the effects of the culture system on EVs. They observed that 3D culture conditions affect the size of the released EVs, inducing the production of smaller vesicles, with size and concentrations comparable to the exosomes isolated from patient plasma. In addition, Ewing’s sarcoma type 1 EVs isolated from 3D cultures proved to have higher similarity to the EVs isolated from patient plasma compared to the same cancer cells cultured as monolayer (; Figure 2). A recent study demonstrated the ability of organoids to intake and respond to EVs (). They showed how human normal gastric organoids responded to tumor-derived EVs content by acquiring a neoplastic phenotype. EVs-treated organoids showed increased proliferation and smaller lumens with multilayered morphology that is typical of neoplastic organoids, along with decreased expression of the tumor suppressors PTEN and AIFM3. In a colorectal cancer organotypic model, EVs purified from human colon fibroblasts grown in hypoxic conditions were able to induce increase in number of neoplastic organoids, suggesting a role of fibroblast-derived EVs in tumorigenesis (). In the same work, the introduction of Apc mutation into mouse small intestinal organoids by CRISPR-Cas9, and the consequent activation of Wnt pathway, enhanced EVs secretion already at the adenoma stage of the intestinal tumorigenesis ().
FIGURE 2
Another crucial advantage of 3D culture system is the possibility of modeling cell-to-matrix interactions, which appear to influence release of EVs. Indeed, it has been shown that matrix supporting organoids growth influences the production of EVs, specifically the enrichment of collagen type I increased the release of EVs in the culture media by colorectal cancer-derived organoids ().
Additionally, tumor-derived EVs presence in body fluids makes them a promising source of cancer biomarkers. EVs miRNA signatures already proved to have prognostic value in several cancer types, including colorectal cancer (), pancreatic cancer (), prostate cancer (), non-small cell lung cancers (), and glioblastoma (). A novel approach using organoid media supernatant has been proposed for the identification of EVs proteins present exclusively in the blood of PDAC patients, and not in patients disease-free or with benign conditions (). The subsequent validation of EV proteins obtained from media supernatant in clinical samples demonstrated the ability of the organoid platform to enable the identification of cancer biomarkers for PDAC patients. Moreover, recent evidences suggest EVs potential role in early disease detection () and prediction of response to treatment (; ; ). The ability to enter other cells and deliver a functional cargo, even at distant sites, without inducing toxicity makes them good therapeutic agents vehicles (). EVs can be engineered to target specific cell types, deliver chemotherapeutic agents () and enhance antitumor immune response (). In conclusion, although patient-derived organoids might be a promising system to study cell-to-cell interactions, additional efforts from the scientific community are expected to finally assess their potential to model EV-based communication in cancers. Given the heterogeneity of matrices used in 3D culture systems, greater efforts are also expected to analyze the different effects of matrices on the migration and biological effect of EVs.
Organotypic System Challenges
Organoids are the in vitro system with a higher degree of similarity with the tissue of origin as compared to conventional monolayer cultures. Integration of different cell types through co-culture systems may help modeling the cell-to-cell interactions observed in vivo. However, beyond the evident advantages offered by the system, some challenges still need to be solved.
Epithelial organoid cultures usually need to be grown in a matrix that allows the formation of 3D structures and sustains their proliferation. The most commonly used matrices are biologically derived materials such as rat tail collagen I and Matrigel® (Table 1). Animal-derived matrices suffer from lot-to-lot variability, both in terms of composition and structure, and are unsuitable for clinical applications (; ). Recently, efforts have been made toward establishing synthetic ECM analogs able to replace animal-derived matrices, with the aim to obtain more characterized and less variable matrix composition, with translational potential. Synthetically produced matrices can be composed by natural or non-natural polymers. An example of natural polymers matrix is the hyaluronic acid (HA) hydrogel, a highly biocompatible material that guarantee batch-to-batch consistency and reproducible results (). On the other hand, non-natural polymers like polyethylene glycol (PEG) are less expensive, highly reproducible, but lack biological features necessary to reproduce natural ECM, to overcome this issue and to improve functionality, natural peptides need to be crosslinked to the scaffold (). developed a synthetic hydrogel for intestinal stem cells organoids generation and growth. PEG hydrogel supplemented with an RGD (Arg-Gly-Asp) peptide supported the expansion of intestinal stem cells, preserving the stemness partly lost during Matrigel® culture. Moreover, they proved that matrix stiffness and composition influence the formation and the differentiation of organoids. For this reason, they proposed the use of a mechanically static PEG to grow intestinal stem cells as spheroids, that successively need to be partially replaced by more degradable PEG to obtain the softness required for the cell’s differentiation and the formation of 3D structures. A different synthetic matrix, composed by PEG with maleimide groups at each terminus (PEG-4MAL), has been also applied for the growth, expansion and differentiation of human intestinal organoids (). An initial 2D culture on Matrigel®-coated substrate was necessary before the encapsulation of cells in PEG-4MAL. The synthetic matrix has been engineered to obtain the optimal polymer density to support the generation of organoids derived from both ESCs and iPSCs. Furthermore, the delivery of human intestinal organoids resuspended in PEG-4MAL hydrogel into injured intestinal mucosa, improved wound repair in a mouse model, suggesting hydrogel as potential vehicle for clinical applications. To overcome the limitations of PEG hydrogel, a fibrin/laminin hydrogel has been developed for the generation and the expansion of epithelial organoids (). Fibrin/laminin hydrogel proved to support long-term expansion of organoids established from different tissues, maintaining the same architecture observed in Matrigel®, giving proof to be a valid candidate for Matrigel® replacement.
TABLE 1
| Matrix | Composition | Derivation | Applications |
| Matrigel® | collagen type IV, laminin, heparan sulfate proteoglycans, entactin/nidogen, and a number of growth factors | murine Englebreth-Holm-Swarm sarcoma tumors | 3D cell culture |
| Collagen type I | collagen type I | rat tail | 3D cell culture |
| HA hydrogel | hyaluronic acid | synthetic | 3D cell culture; clinical applications |
| PEG hydrogel | polyethylene glycol (PEG) hydrogel supplemented with an RGD (Arg-Gly-Asp) peptide | synthetic | 3D cell culture; clinical applications |
| PEG-4MAL hydrogel | PEG with maleimide groups at each terminus | synthetic | 3D cell culture; clinical applications |
| Fibrin/laminin hydrogel | fibrin, laminin | synthetic | 3D cell culture; clinical applications |
Most commonly used matrices for the growth of 3D cultures.
The other critical aspect of the organoids system is the formulation of an optimal culture media that contains the niche factors necessary for the establishment and the long-term culture of organoids. Wnt3a and R-spondin1 have been proven to be essential niche components for the establishment of patient-derived organoids from different tissues, like pancreas, liver, stomach and intestine (). Although in the first organoid protocol it was reported the use of purified proteins (), currently, the production of these two factors in many laboratories relies on eukaryotic cell culture engineered to secrete Wnt3a and R-spondin into their culture media due to economical constraints. The obtained conditioned media are then used for the production of the organoid culture media. Clearly, the use of conditioned media introduces elements of variability in the culture system and makes difficult comparing data generated from different laboratories. Moreover, the presence of other macromolecules, apart from the protein of interest, and batch-to-batch variability of protein activity may affect the organoid growth. Replacing conditioned media with recombinant proteins displaying similar activity may lead to the definition of standardized media conditions for the establishment of patient-derived organoids. Efforts have been recently made in this direction with the production of recombinant R-spondin () and Wnt surrogate ().
Concluding Remarks
The advent of 3D culture systems is enabling the systematic generation of in vitro models from a variety of cancers and normal tissues. Increasing evidences suggest that those cultures are genetically stable and faithfully recapitulate major molecular features of parental tissues. The integration of these new systems with improved methods for isolation and characterization of EVs offers now the opportunity of exploring the role of unconventional ways of communications between cells, which has been shown to influence many aspects of cancer biology, including metastasis. Ultimately, the possibility to isolate and culture both tumoral and non-tumoral cells from the same patient permits the assessment of malignant specific features that has never been possible before using in vitro system for many cancer types.
Statements
Author contributions
EF wrote the manuscript and performed literature search. LV prepared the figures. EF and LV drafted the manuscript. VC devised the idea and finalized the manuscript.
Funding
VC was supported by the Associazione Italiana Ricerca sul Cancro (AIRC; Grant No. 18178), while both EF and LV were supported by the Fondazione Cariverona.
Acknowledgments
We thank all the members of the Corbo’s lab for support and critical review of the manuscript.
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
References
1
AbusamraA. J.ZhongZ.ZhengX.LiM.IchimT. E.ChinJ. L.et al (2005). Tumor exosomes expressing Fas ligand mediate CD8+ T-cell apoptosis.Blood Cells Mol. Dis.35169–173. 10.1016/j.bcmd.2005.07.001
2
AvnetS.LemmaS.CortiniM.Di PompoG.PerutF.BaldiniN. (2019). Pre-clinical models for studying the interaction between mesenchymal stromal cells and cancer cells and the induction of stemness.Front. Oncol.9:305. 10.3389/fonc.2019.00305
3
Barcellos-HoffM. H.AggelerJ.RamT. G.BissellM. J. (1989). Functional differentiation and alveolar morphogenesis of primary mammary cultures on reconstituted basement membrane.Development105223–235.
4
BarkerN.HuchM.KujalaP.van de WeteringM.SnippertH. J.vanJ. H. (2010). Lgr5(+ve) stem cells drive self-renewal in the stomach and build long-lived gastric units in vitro.Cell Stem Cell625–36. 10.1016/j.stem.2009.11.013
5
Ben-DavidU.HaG.TsengY. Y.GreenwaldN. F.OhC.ShihJ. (2017). Patient-derived xenografts undergo mouse-specific tumor evolution.Nat. Genet.491567–1575. 10.1038/ng.3967
6
BesseB.CharrierM.LapierreV.DansinE.LantzO.PlanchardD. (2016). Dendritic cell-derived exosomes as maintenance immunotherapy after first line chemotherapy in NSCLC.Oncoimmunology5:e1071008. 10.1080/2162402x.2015.1071008
7
BissellM. J. (1981). The differentiated state of normal and malignant cells or how to define a “normal” cell in culture.Int. Rev. Cytol.7027–100. 10.1016/s0074-7696(08)61130-4
8
BoelensM. C.WuT. J.NabetB. Y.XuB.QiuY.YoonT. (2014). Exosome transfer from stromal to breast cancer cells regulates therapy resistance pathways.Cell159499–513. 10.1016/j.cell.2014.09.051
9
BojS. F.HwangC. I.BakerL. A.ChioI. I.EngleD. D.CorboV. (2015). Organoid models of human and mouse ductal pancreatic cancer.Cell160324–338. 10.1016/j.cell.2014.12.021
10
BroguiereN.IsenmannL.HirtC.RingelT.PlaczekS.CavalliE. (2018). Growth of epithelial organoids in a defined hydrogel.Adv. Mater.30:e1801621. 10.1002/adma.201801621
11
BroutierL.MastrogiovanniG.VerstegenM. M.FranciesH. E.GavarroL. M.BradshawC. R. (2017). Human primary liver cancer-derived organoid cultures for disease modeling and drug screening.Nat. Med.231424–1435. 10.1038/nm.4438
12
BurdickJ. A.PrestwichG. D. (2011). Hyaluronic acid hydrogels for biomedical applications.Adv. Mater.23H41–H56. 10.1002/adma.201003963
13
ChenG.HuangA. C.ZhangW.ZhangG.WuM.XuW. (2018). Exosomal PD-L1 contributes to immunosuppression and is associated with anti-PD-1 response.Nature560382–386. 10.1038/s41586-018-0392-8
14
CheonD. J.OrsulicS. (2011). Mouse models of cancer.Annu. Rev. Pathol.695–119. 10.1146/annurev.pathol.3.121806.154244
15
CiravoloV.HuberV.GhediniG. C.VenturelliE.BianchiF.CampiglioM. (2012). Potential role of HER2-overexpressing exosomes in countering trastuzumab-based therapy.J. Cell. Physiol.227658–667. 10.1002/jcp.22773
16
CleversH.NusseR. (2012). Wnt/beta-catenin signaling and disease.Cell1491192–1205.
17
CostaE. C.MoreiraA. F.de Melo-DiogoD.GasparV. M.CarvalhoM. P.CorreiaI. J. (2016). 3D tumor spheroids: an overview on the tools and techniques used for their analysis.Biotechnol. Adv.341427–1441. 10.1016/j.biotechadv.2016.11.002
18
Costa-SilvaB.AielloN. M.OceanA. J.SinghS.ZhangH.ThakurB. K. (2015). Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver.Nat. Cell Biol.17816–826.
19
Cruz-AcunaR.QuirosM.FarkasA. E.DedhiaP. H.HuangS.SiudaD. (2017). Synthetic hydrogels for human intestinal organoid generation and colonic wound repair.Nat. Cell Biol.191326–1335. 10.1038/ncb3632
20
D’AgostoS.AndreaniS.ScarpaA.CorboV. (2019). Preclinical Modelling of PDA: Is Organoid the New Black?Int. J. Mol. Sci20:2766. 10.3390/ijms20112766
21
DaleyW. P.PetersS. B.LarsenM. (2008). Extracellular matrix dynamics in development and regenerative medicine.J. Cell Sci.121255–264. 10.1242/jcs.006064
22
Di VizioD.MorelloM.DudleyA. C.SchowP. W.AdamR. M.MorleyS. (2012). Large oncosomes in human prostate cancer tissues and in the circulation of mice with metastatic disease.Am. J. Pathol.1811573–1584. 10.1016/j.ajpath.2012.07.030
23
DijkstraK. K.CattaneoC. M.WeeberF.ChalabiM.van de HaarJ.FanchiL. F. (2018). Generation of tumor-reactive T cells by co-culture of peripheral blood lymphocytes and tumor organoids.Cell1741586–1598.e12. 10.1016/j.cell.2018.07.009
24
DrostJ.KarthausW. R.GaoD.DriehuisE.SawyersC. L.ChenY.et al (2016). Organoid culture systems for prostate epithelial and cancer tissue.Nat. Protoc.11347–358. 10.1038/nprot.2016.006
25
EirakuM.WatanabeK.Matsuo-TakasakiM.KawadaM.YonemuraS.MatsumuraM. (2008). Self-organized formation of polarized cortical tissues from ESCs and its active manipulation by extrinsic signals.Cell Stem Cell3519–532. 10.1016/j.stem.2008.09.002
26
EirewP.SteifA.KhattraJ.HaG.YapD.FarahaniH. (2015). Dynamics of genomic clones in breast cancer patient xenografts at single-cell resolution.Nature518422–426. 10.1038/nature13952
27
ElyadaE.BolisettyM.LaiseP.FlynnW. F.CourtoisE. T.BurkhartR. A. (2019). Cross-species single-cell analysis of pancreatic ductal adenocarcinoma reveals antigen-presenting cancer-associated fibroblasts.Cancer Discov.91102–1123. 10.1158/2159-8290.CD-19-0094
28
FangT.LvH.LvG.LiT.WangC.HanQ. (2018). Tumor-derived exosomal miR-1247-3p induces cancer-associated fibroblast activation to foster lung metastasis of liver cancer.Nat. Commun.9:191. 10.1038/s41467-017-02583-0
29
FergusonS. W.NguyenJ. (2016). Exosomes as therapeutics: the implications of molecular composition and exosomal heterogeneity.J. Control. Release228179–190. 10.1016/j.jconrel.2016.02.037
30
FongE. L.HarringtonD. A.CarsonF.-C.YuH. (2016). Heralding a new paradigm in 3D tumor modeling.Biomaterials108197–213. 10.1016/j.biomaterials.2016.08.052
31
FuF.JiangW.ZhouL.ChenZ. (2018). Circulating exosomal miR-17-5p and miR-92a-3p predict pathologic stage and grade of colorectal cancer.Transl. Oncol.11221–232. 10.1016/j.tranon.2017.12.012
32
FukunagaA.MiyamotoM.ChoY.MurakamiS.KawaradaY.OshikiriT. (2004). CD8+ tumor-infiltrating lymphocytes together with CD4+ tumor-infiltrating lymphocytes and dendritic cells improve the prognosis of patients with pancreatic adenocarcinoma.Pancreas28e26–e31. 10.1097/00006676-200401000-00023
33
GiandomenicoS. L.MierauS. B.GibbonsG. M.WengerL. M. D.MasulloL.SitT. (2019). Cerebral organoids at the air-liquid interface generate diverse nerve tracts with functional output.Nat. Neurosci.22669–679. 10.1038/s41593-019-0350-2
34
GjorevskiN.SachsN.ManfrinA.GigerS.BraginaM. E.Ordonez-MoranP. (2016). Designer matrices for intestinal stem cell and organoid culture.Nature539560–564. 10.1038/nature20168
35
GotoT.FujiyaM.KonishiH.SasajimaJ.FujibayashiS.HayashiA. (2018). An elevated expression of serum exosomal microRNA-191, - 21, -451a of pancreatic neoplasm is considered to be efficient diagnostic marker.BMC Cancer18:116. 10.1186/s12885-018-4006-5
36
GrassiL.AlfonsiR.FrancescangeliF.SignoreM.De AngelisM. L.AddarioA. (2019). Organoids as a new model for improving regenerative medicine and cancer personalized therapy in renal diseases.Cell Death Dis.10:201. 10.1038/s41419-019-1453-0
37
HoshinoA.Costa-SilvaB.ShenT. L.RodriguesG.HashimotoA.Tesic MarkM. (2015). Tumour exosome integrins determine organotropic metastasis.Nature527329–335. 10.1038/nature15756
38
HuangL.BockornyB.PaulI.AkshinthalaD.GandarillaO.BoseA. (2019). Pancreatic tumor organoids for modeling in vivo drug response and discovering clinically-actionable biomarkers.bioRxiv [Preprint]. 10.1101/513267
39
HuchM.BonfantiP.BojS. F.SatoT.LoomansC. J.van de WeteringM. (2013a). Unlimited in vitro expansion of adult bi-potent pancreas progenitors through the Lgr5/R-spondin axis.EMBO J.322708–2721. 10.1038/emboj.2013.204
40
HuchM.DorrellC.BojS. F.van EsJ. H.LiV. S.van de WeteringM. (2013b). In vitro expansion of single Lgr5+ liver stem cells induced by Wnt-driven regeneration.Nature494247–250. 10.1038/nature11826
41
HughesC. S.PostovitL. M.LajoieG. A. (2010). Matrigel: a complex protein mixture required for optimal growth of cell culture.Proteomics101886–1890. 10.1002/pmic.200900758
42
HynesR. O. (2009). The extracellular matrix: not just pretty fibrils.Science3261216–1219. 10.1126/science.1176009
43
JandaC. Y.DangL. T.YouC.ChangJ.de LauW.ZhongZ. A. (2017). Surrogate Wnt agonists that phenocopy canonical Wnt and beta-catenin signalling.Nature545234–237. 10.1038/nature22306
44
JenkinsR. W.ArefA. R.LizotteP. H.IvanovaE.StinsonS.ZhouC. W. (2018). Ex vivo profiling of PD-1 blockade using organotypic tumor spheroids.Cancer Discov.8196–215. 10.1158/2159-8290.CD-17-0833
45
KaragiannisG. S.PavlouM. P.DiamandisE. P. (2010). Cancer secretomics reveal pathophysiological pathways in cancer molecular oncology.Mol. Oncol.4496–510. 10.1016/j.molonc.2010.09.001
46
KattM. E.PlaconeA. L.WongA. D.XuZ. S.SearsonP. C. (2016). In vitro tumor models: advantages, disadvantages, variables, and selecting the right platform.Front. Bioeng. Biotechnol.4:12. 10.3389/fbioe.2016.00012
47
KeX.YanR.SunZ.ChengY.MeltzerA.LuN. (2017). Esophageal adenocarcinoma-derived extracellular vesicle micrornas induce a neoplastic phenotype in gastric organoids.Neoplasia19941–949. 10.1016/j.neo.2017.06.007
48
KhongH. T.RestifoN. P. (2002). Natural selection of tumor variants in the generation of “tumor escape” phenotypes.Nat. Immunol.3999–1005. 10.1038/ni1102-999
49
KimM. S.HaneyM. J.ZhaoY.MahajanV.DeygenI.KlyachkoN. L. (2016). Development of exosome-encapsulated paclitaxel to overcome MDR in cancer cells.Nanomedicine12655–664. 10.1016/j.nano.2015.10.012
50
KowalJ.TkachM.TheryC. (2014). Biogenesis and secretion of exosomes.Curr. Opin. Cell Biol.29116–125. 10.1016/j.ceb.2014.05.004
51
LabernadieA.KatoT.BruguesA.Serra-PicamalX.DerzsiS.ArwertE. (2017). A mechanically active heterotypic E-cadherin/N-cadherin adhesion enables fibroblasts to drive cancer cell invasion.Nat. Cell Biol.19224–237. 10.1038/ncb3478
52
LancasterM. A.KnoblichJ. A. (2014). Organogenesis in a dish: modeling development and disease using organoid technologies.Science345:1247125. 10.1126/science.1247125
53
LancasterM. A.RennerM.MartinC. A.WenzelD.BicknellL. S.HurlesM. E. (2013). Cerebral organoids model human brain development and microcephaly.Nature501373–379. 10.1038/nature12517
54
LeBleuV. S.KalluriR. (2018). A peek into cancer-associated fibroblasts: origins, functions and translational impact.Dis. Model. Mech.11:dmm029447. 10.1242/dmm.029447
55
LecaJ.MartinezS.LacS.NigriJ.SecqV.RubisM. (2016). Cancer-associated fibroblast-derived annexin A6+ extracellular vesicles support pancreatic cancer aggressiveness.J. Clin. Invest.1264140–4156. 10.1172/JCI87734
56
LeeG. Y.KennyP. A.LeeE. H.BissellM. J. (2007). Three-dimensional culture models of normal and malignant breast epithelial cells.Nat. Methods4359–365. 10.1038/nmeth1015
57
LiB.AntonyakM. A.ZhangJ.CerioneR. A. (2012). RhoA triggers a specific signaling pathway that generates transforming microvesicles in cancer cells.Oncogene314740–4749. 10.1038/onc.2011.636
58
LiX.FranciesH. E.SecrierM.PernerJ.MiremadiA.Galeano-DalmauN. (2018). Organoid cultures recapitulate esophageal adenocarcinoma heterogeneity providing a model for clonality studies and precision therapeutics.Nat. Commun.9:2983. 10.1038/s41467-018-05190-9
59
LiX.NadauldL.OotaniA.CorneyD. C.PaiR. K.GevaertO. (2014). Oncogenic transformation of diverse gastrointestinal tissues in primary organoid culture.Nat. Med.20769–777. 10.1038/nm.3585
60
LindeN.GutschalkC. M.HoffmannC.YilmazD.MuellerM. M. (2012). Integrating macrophages into organotypic co-cultures: a 3D in vitro model to study tumor-associated macrophages.PLoS One7:e40058. 10.1371/journal.pone.0040058
61
LinkousA.BalamatsiasD.SnuderlM.EdwardsL.MiyaguchiK.MilnerT. (2019). Modeling patient-derived glioblastoma with cerebral organoids.Cell Rep.263203–3211.e5. 10.1016/j.celrep.2019.02.063
62
LiuQ.YuZ.YuanS.XieW.LiC.HuZ. (2017). Circulating exosomal microRNAs as prognostic biomarkers for non-small-cell lung cancer.Oncotarget813048–13058. 10.18632/oncotarget.14369
63
LugaV.ZhangL.Viloria-PetitA. M.OgunjimiA. A.InanlouM. R.ChiuE. (2012). Exosomes mediate stromal mobilization of autocrine Wnt-PCP signaling in breast cancer cell migration.Cell1511542–1556. 10.1016/j.cell.2012.11.024
64
MarusykA.TabassumD. P.JaniszewskaM.PlaceA. E.TrinhA.RozhokA. I. (2016). Spatial proximity to fibroblasts impacts molecular features and therapeutic sensitivity of breast cancer cells influencing clinical outcomes.Cancer Res.766495–6506. 10.1158/0008-5472.CAN-16-1457
65
MeehanB.RakJ.Di VizioD. (2016). Oncosomes - large and small: what are they, where they came from?J. Extracell. Vesicles5:33109. 10.3402/jev.v5.33109
66
MeloS. A.LueckeL. B.KahlertC.FernandezA. F.GammonS. T.KayeJ. (2015). Glypican-1 identifies cancer exosomes and detects early pancreatic cancer.Nature523177–182. 10.1038/nature14581
67
MinciacchiV. R.SpinelliC.Reis-SobreiroM.CavalliniL.YouS.ZandianM. (2017). MYC mediates large oncosome-induced fibroblast reprogramming in prostate cancer.Cancer Res.772306–2317. 10.1158/0008-5472.can-16-2942
68
MinciacchiV. R.YouS.SpinelliC.MorleyS.ZandianM.AspuriaP. J. (2015). Large oncosomes contain distinct protein cargo and represent a separate functional class of tumor-derived extracellular vesicles.Oncotarget611327–11341.
69
MosconaA.MosconaH. (1952). The dissociation and aggregation of cells from organ rudiments of the early chick embryo.J. Anat.86287–301.
70
NaitoY.YamamotoY.SakamotoN.ShimomuraI.KogureA.KumazakiM. (2019). Cancer extracellular vesicles contribute to stromal heterogeneity by inducing chemokines in cancer-associated fibroblasts.Oncogene385566–5579. 10.1038/s41388-019-0832-4
71
NeaguM. (2012). The immune system–a hidden treasure for biomarker discovery in cutaneous melanoma.Adv. Clin. Chem.5889–140. 10.1016/b978-0-12-394383-5.00011-4
72
NealJ. T.LiX.ZhuJ.GiangarraV.GrzeskowiakC. L.JuJ. (2018). Organoid modeling of the tumor immune microenvironment.Cell1751972–1988.e16. 10.1016/j.cell.2018.11.021
73
OhlundD.Handly-SantanaA.BiffiG.ElyadaE.AlmeidaA. S.Ponz-SarviseM. (2017). Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer.J. Exp. Med.214579–596. 10.1084/jem.20162024
74
OotaniA.LiX.SangiorgiE.HoQ. T.UenoH.TodaS. (2009). Sustained in vitro intestinal epithelial culture within a Wnt-dependent stem cell niche.Nat. Med.15701–706. 10.1038/nm.1951
75
OrkinR. W.GehronP.McGoodwinE. B.MartinG. R.ValentineT.SwarmR. (1977). A murine tumor producing a matrix of basement membrane.J. Exp. Med.145204–220. 10.1084/jem.145.1.204
76
OzdemirB. C.Pentcheva-HoangT.CarstensJ. L.ZhengX.WuC. C.SimpsonT. R. (2014). Depletion of carcinoma-associated fibroblasts and fibrosis induces immunosuppression and accelerates pancreas cancer with reduced survival.Cancer Cell25719–734. 10.1016/j.ccr.2014.04.005
77
ParaisoK. H.SmalleyK. S. (2013). Fibroblast-mediated drug resistance in cancer.Biochem. Pharmacol.851033–1041. 10.1016/j.bcp.2013.01.018
78
PeinadoH.AleckovicM.LavotshkinS.MateiI.Costa-SilvaB.Moreno-BuenoG. (2012). Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET.Nat. Med.18883–891. 10.1038/nm.2753
79
PetersenO. W.Ronnov-JessenL.HowlettA. R.BissellM. J. (1992). Interaction with basement membrane serves to rapidly distinguish growth and differentiation pattern of normal and malignant human breast epithelial cells.Proc. Natl. Acad. Sci. U.S.A.899064–9068. 10.1073/pnas.89.19.9064
80
PringleS.MaimetsM.van der ZwaagM.StokmanM. A.van GosligaD.ZwartE. (2016). Human salivary gland stem cells functionally restore radiation damaged salivary glands.Stem Cells34640–652. 10.1002/stem.2278
81
PucciF.GarrisC.LaiC. P.NewtonA.PfirschkeC.EngblomC. (2016). SCS macrophages suppress melanoma by restricting tumor-derived vesicle-B cell interactions.Science352242–246. 10.1126/science.aaf1328
82
RangarajanA.WeinbergR. A. (2003). Opinion: comparative biology of mouse versus human cells: modelling human cancer in mice.Nat. Rev. Cancer3952–959. 10.1038/nrc1235
83
RatajczakJ.MiekusK.KuciaM.ZhangJ.RecaR.DvorakP.et al (2006). Embryonic stem cell-derived microvesicles reprogram hematopoietic progenitors: evidence for horizontal transfer of mRNA and protein delivery.Leukemia20847–856. 10.1038/sj.leu.2404132
84
RhimA. D.ObersteinP. E.ThomasD. H.MirekE. T.PalermoC. F.SastraS. A. (2014). Stromal elements act to restrain, rather than support, pancreatic ductal adenocarcinoma.Cancer Cell25735–747. 10.1016/j.ccr.2014.04.021
85
RichardsZ.McCrayT.MarsiliJ.ZennerM. L.ManlucuJ. T.GarciaJ. (2019). Prostate stroma increases the viability and maintains the branching phenotype of human prostate organoids.iScience12304–317. 10.1016/j.isci.2019.01.028
86
RochaS.CarvalhoJ.OliveiraP.VoglstaetterM.SchvartzD.ThomsenA. R. (2019). 3D cellular architecture affects microRNA and protein cargo of extracellular vesicles.Adv. Sci.6:1800948. 10.1002/advs.201800948
87
Rodrigues-JuniorD. M.TanS. S.de Souza VianaL.CarvalhoA. L.LimS. K.IyerN. G.et al (2019). A preliminary investigation of circulating extracellular vesicles and biomarker discovery associated with treatment response in head and neck squamous cell carcinoma.BMC Cancer19:373. 10.1186/s12885-019-5565-9
88
SachsN.de LigtJ.KopperO.GogolaE.BounovaG.WeeberF. (2018). A living Biobank of breast cancer organoids captures disease heterogeneity.Cell172373–386.e10. 10.1016/j.cell.2017.11.010
89
SachsN.PapaspyropoulosA.Zomer-van OmmenD. D.HeoI.BottingerL.KlayD. (2019). Long-term expanding human airway organoids for disease modeling.EMBO J.38:e100300.
90
SantiA.CaselliA.RanaldiF.PaoliP.MugnaioniC.MichelucciE.et al (2015). Cancer associated fibroblasts transfer lipids and proteins to cancer cells through cargo vesicles supporting tumor growth.Biochim. Biophys. Acta18533211–3223. 10.1016/j.bbamcr.2015.09.013
91
SatoE.OlsonS. H.AhnJ.BundyB.NishikawaH.QianF. (2005). Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer.Proc. Natl. Acad. Sci. U.S.A.10218538–18543. 10.1073/pnas.0509182102
92
SatoT.StangeD. E.FerranteM.VriesR. G.Van EsJ. H.Van den BrinkS. (2011). Long-term expansion of epithelial organoids from human colon, adenoma, adenocarcinoma, and Barrett’s epithelium.Gastroenterology1411762–1772. 10.1053/j.gastro.2011.07.050
93
SatoT.VriesR. G.SnippertH. J.van de WeteringM.BarkerN.StangeD. E. (2009). Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche.Nature459262–265. 10.1038/nature07935
94
SchutgensF.RookmaakerM. B.MargaritisT.RiosA.AmmerlaanC.JansenJ. (2019). Tubuloids derived from human adult kidney and urine for personalized disease modeling.Nat. Biotechnol.37303–313. 10.1038/s41587-019-0048-8
95
SeinoT.KawasakiS.ShimokawaM.TamagawaH.ToshimitsuK.FujiiM. (2018). Human pancreatic tumor organoids reveal loss of stem cell niche factor dependence during disease progression.Cell Stem Cell22454–467.e6. 10.1016/j.stem.2017.12.009
96
SkogJ.WurdingerT.van RijnS.MeijerD. H.GaincheL.Sena-EstevesM. (2008). Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers.Nat. Cell Biol.101470–1476. 10.1038/ncb1800
97
SpenceJ. R.MayhewC. N.RankinS. A.KuharM. F.VallanceJ. E.TolleK. (2011). Directed differentiation of human pluripotent stem cells into intestinal tissue in vitro.Nature470105–109. 10.1038/nature09691
98
SwarmR. L. (1963). Transplantation of a murine chondrosarcoma in mice of different inbred strains.J. Natl. Cancer Inst.31953–975.
99
SzvicsekZ.OszvaldA.SzaboL.SandorG. O.KelemenA.SoosA. A. (2019). Extracellular vesicle release from intestinal organoids is modulated by Apc mutation and other colorectal cancer progression factors.Cell. Mol. Life Sci.762463–2476. 10.1007/s00018-019-03052-1
100
TorrasN.Garcia-DiazM.Fernandez-MajadaV.MartinezE. (2018). Mimicking epithelial tissues in three-dimensional cell culture models.Front. Bioeng. Biotechnol.6:197. 10.3389/fbioe.2018.00197
101
TuriakL.MisjakP.SzaboT. G.AradiB.PalocziK.OzohanicsO. (2011). Proteomic characterization of thymocyte-derived microvesicles and apoptotic bodies in BALB/c mice.J. Proteomics742025–2033. 10.1016/j.jprot.2011.05.023
102
UrbischekM.RannikmaeH.FoetsT.RavnK.HyvonenM.de la RocheM. (2019). Organoid culture media formulated with growth factors of defined cellular activity.Sci. Rep.9:6193.
103
UsuiT.SakuraiM.EnjojiS.KawasakiH.UmataK.OhamaT. (2016). Establishment of a novel model for anticancer drug resistance in three-dimensional primary culture of tumor microenvironment.Stem Cells Int.2016:7053872. 10.1155/2016/7053872
104
UsuiT.SakuraiM.UmataK.YamawakiH.OhamaT.SatoK. (2018). Preparation of human primary colon tissue-derived organoid using air liquid interface culture.Curr. Protoc. Toxicol.7522.6.1–22.6.7. 10.1002/cptx.40
105
ValadiH.EkstromK.BossiosA.SjostrandM.LeeJ. J.LotvallJ. O. (2007). Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells.Nat. Cell Biol.9654–659. 10.1038/ncb1596
106
ValentinoA.ReclusaP.SireraR.GiallombardoM.CampsC.PauwelsP. (2017). Exosomal microRNAs in liquid biopsies: future biomarkers for prostate cancer.Clin. Transl. Oncol.19651–657. 10.1007/s12094-016-1599-5
107
VillasanteA.Marturano-KruikA.AmbatiS. R.LiuZ.Godier-FurnemontA.ParsaH. (2016). Recapitulating the size and cargo of tumor exosomes in a tissue-engineered model.Theranostics61119–1130. 10.7150/thno.13944
108
VukicevicS.KleinmanH. K.LuytenF. P.RobertsA. B.RocheN. S.ReddiA. H. (1992). Identification of multiple active growth factors in basement membrane Matrigel suggests caution in interpretation of cellular activity related to extracellular matrix components.Exp. Cell Res.2021–8. 10.1016/0014-4827(92)90397-q
109
WangJ.WangL.LinZ.TaoL.ChenM. (2014). More efficient induction of antitumor T cell immunity by exosomes from CD40L gene-modified lung tumor cells.Mol. Med. Rep.9125–131. 10.3892/mmr.2013.1759
110
WangK.YuenS. T.XuJ.LeeS. P.YanH. H.ShiS. T. (2014). Whole-genome sequencing and comprehensive molecular profiling identify new driver mutations in gastric cancer.Nat. Genet.46573–582. 10.1038/ng.2983
111
WebberJ. P.SparyL. K.SandersA. J.ChowdhuryR.JiangW. G.SteadmanR. (2015). Differentiation of tumour-promoting stromal myofibroblasts by cancer exosomes.Oncogene34290–302. 10.1038/onc.2013.560
112
WeiY.LaiX.YuS.ChenS.MaY.ZhangY. (2014). Exosomal miR-221/222 enhances tamoxifen resistance in recipient ER-positive breast cancer cells.Breast Cancer Res. Treat.147423–431. 10.1007/s10549-014-3037-0
113
WeiswaldL. B.BelletD.Dangles-MarieV. (2015). Spherical cancer models in tumor biology.Neoplasia171–15. 10.1016/j.neo.2014.12.004
114
WorthingtonP.PochanD. J.LanghansS. A. (2015). Peptide hydrogels - versatile matrices for 3D cell culture in cancer medicine.Front. Oncol.5:92. 10.3389/fonc.2015.00092
115
WuX.Peters-HallJ. R.BoseS.PenaM. T.RoseM. C. (2011). Human bronchial epithelial cells differentiate to 3D glandular acini on basement membrane matrix.Am. J. Respir. Cell Mol. Biol.44914–921. 10.1165/rcmb.2009-0329OC
116
YangL.YangS.LiX.LiB.LiY.ZhangX. (2019). Tumor organoids: From inception to future in cancer research.Cancer Lett.454120–133. 10.1016/j.canlet.2019.04.005
117
YokoboriT.SuzukiS.MiyazakiT.SohdaM.SakaiM.TanakaN. (2016). Intestinal epithelial culture under an air-liquid interface: a tool for studying human and mouse esophagi.Dis. Esophagus29843–847. 10.1111/dote.12346
118
YokoiA.YoshiokaY.YamamotoY.IshikawaM.IkedaS. I.KatoT. (2017). Malignant extracellular vesicles carrying MMP1 mRNA facilitate peritoneal dissemination in ovarian cancer.Nat. Commun.8:14470. 10.1038/ncomms14470
119
ZhangD.LiL.JiangH.LiQ.Wang-GillamA.YuJ. (2018). Tumor-stroma IL1beta-IRAK4 feedforward circuitry drives tumor fibrosis, chemoresistance, and poor prognosis in pancreatic cancer.Cancer Res.781700–1712. 10.1158/0008-5472.CAN-17-1366
120
ZiaiJ.GilbertH. N.ForemanO.Eastham-AndersonJ.ChuF.HuseniM.et al (2018). CD8+ T cell infiltration in breast and colon cancer: a histologic and statistical analysis.PLoS One13:e0190158. 10.1371/journal.pone.0190158
Summary
Keywords
tumor microenvironment, co-culture systems, extracellular vesicles, organoids, extracellular matrix
Citation
Fiorini E, Veghini L and Corbo V (2020) Modeling Cell Communication in Cancer With Organoids: Making the Complex Simple. Front. Cell Dev. Biol. 8:166. doi: 10.3389/fcell.2020.00166
Received
13 December 2019
Accepted
28 February 2020
Published
18 March 2020
Volume
8 - 2020
Edited by
Hatem E. Sabaawy, Rutgers, The State University of New Jersey, United States
Reviewed by
Yoshitaka Hippo, Chiba Cancer Center, Japan; Mary C. Farach-Carson, University of Texas Health Science Center at Houston, United States
Updates
Copyright
© 2020 Fiorini, Veghini and Corbo.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Vincenzo Corbo, vincenzo.corbo@univr.it
This article was submitted to Stem Cell Research, a section of the journal Frontiers in Cell and Developmental Biology
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.